Ashland (ASH) has drawn attention after its board declared a quarterly cash dividend of $0.42 per share and added two directors to key board committees on August 7, 2026.

Ashland’s recent dividend declaration and board committee changes come after a strong run in the stock, with a 90-day share price return of 35.25% and a 1-year total shareholder return of 40.94%. However, the 3-year and 5-year total shareholder returns show declines of 8.00% and 2.76% respectively, suggesting that recent momentum has picked up after a weaker longer-term stretch.

If Ashland’s recent move has you thinking about where else to put fresh capital to work, this could be a good moment to uncover 20 top founder-led companies

The recent jump in Ashland's share price leaves a clear gap between the current US$73.71 level, the roughly US$80 analyst target, and a deeper intrinsic estimate. So where does fair value really sit now?

Most Popular Narrative: 8.1% Undervalued

Ashland's most followed narrative puts fair value at $80.18, which sits above the latest close at $73.71 and frames the current valuation debate.

The global shift toward sustainable and bio-based materials driven by regulatory requirements and consumer preference, continues to gain momentum, benefiting Ashland's specialty chemicals portfolio that is now more focused on high-value, sustainable, and compliant solutions. This is expected to support top-line revenue growth and margin resilience over the long term.

Want to see what is really backing that fair value for Ashland? The narrative leans heavily on future earnings power, richer margins, and a specific profit multiple. Curious which assumptions do the heavy lifting behind that $80.18 number?

Result: Fair Value of $80.18 (UNDERVALUED)

However, Ashland's heavy tilt toward personal care and life sciences, along with ongoing pressure in Specialty Additives, could restrain revenue and margin progress if demand stays weak.

Another Take On Ashland’s Valuation

The SWS DCF model points to a fair value of about $100.04 for Ashland compared with the current $73.71 share price. That suggests a wider undervaluation than the $80.18 narrative target. If the cash flow view is closer to reality, the market may still be underestimating Ashland.

Next Steps

With mixed signals around Ashland and a split between risks and rewards, this is a moment to move fast and test the thesis yourself. Start by weighing the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Ashland?

If Ashland has sharpened your interest, do not stop here. Use the Simply Wall St screener to quickly surface fresh stock ideas that match your style.

• Target dependable income streams by reviewing companies in the 10 dividend fortresses that may suit a dividend focused approach.
• Hunt for potential value opportunities by checking out the 50 high quality undervalued stocks that fit tighter quality and pricing filters.
• Prioritise resilience by scanning the 83 resilient stocks with low risk scores to see which stocks line up with a more conservative risk profile.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.